TENX Oxygen Biotherapeutics Inc

Tenax Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing & commercializing pharmaceutical products for critical care patients and its products include Levosimendan & Oxycyte.

$0.39  +0.07 (24.10%)
As of 06/27/2022 16:00:00 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/15/2010
Outstanding shares:  25,206,914
Average volume:  217,811
Market cap:   $7,824,226
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   1.85
PS ratio:   0.00
Return on equity:   765.06%
Net income %:   0.00%